Social anxiety (anxiety in social situations)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients >=18 years of age - Sufficient mastery of the Dutch language and ability to complete questionnaires and understand informed consent information - Meeting DSM-5 criteria for social anxiety disorder (assessed with MINI-S-DSM-5). - Stable medication for at least six weeks before starting participation in the study and willingness by the patient and physician to keep the medication stable during the study period. The use of sedating medication (e.g. benzodiazepines) is no contraindication however, participants are strongly advised not to use sedating medication prior to- or after treatment sessions and subsequent days. The use of sedating medication will be registered - Self-reported ability to refrain from alcohol or drugs 24 hours before and after each session. General use of alcohol or drugs will be discouraged.
Exclusion criteria
Exclusion criteria: - Self-reported neurological disorder - Acute or recent history of suicide attempts according to the (MINI-S-DSM-5) section C - Self-reported visual or auditory impairments that could hinder treatment - Self-reported current psychological treatment for other DSM-5 disorders - Being reluctant or unable to complete questionnaires online
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes are: 1. social anxiety symptoms. 2. Social avoidance symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are: Weekly social anxiety symptom severity. | — |
Countries
Netherlands